Stock S1RP34 SAREPTA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Sarepta Therapeutics, Inc. Sao Paulo

Equities

S1RP34

BRS1RPBDR005

Market Closed - Sao Paulo
Other stock markets
 14:24:21 2024-06-25 EDT 		5-day change 1st Jan Change
43.1 BRL -1.87% Intraday chart for Sarepta Therapeutics, Inc. +33.15% +87.72%
06-24 Morgan Stanley Adjusts Sarepta Therapeutics' Price Target to $200 From $165, Keeps Overweight Rating MT
06-24 Evercore ISI Raises Price Target on Sarepta Therapeutics to $185 From $139, Maintains In Line Rating MT

Chart calendar Sarepta Therapeutics, Inc.

4ef466f7192df946d469.M8a3Yhtiq7-65UfSMqkCJpWNwvl5tqmgz5WcKbyIts0.Af7_A1pR2tv3qz-mUNFKR83vpr4fgO-RuaPXBP7Q7JxkpM0OVBaT_PXQAg~f82c62b0a15f3ed4a0f90af75363826c

Upcoming events on Sarepta Therapeutics, Inc.

2024-07-30 Q2 2024 Earnings Release (Projected)
2024-10-29 Q3 2024 Earnings Release (Projected)
2025-03-03 Q4 2024 Earnings Release (Projected)
2025-04-29 Q1 2025 Earnings Release (Projected)

Past events on Sarepta Therapeutics, Inc.

2024-06-21 08:30 ELEVIDYS Label Update Call
2024-06-06 10:00 Annual General Meeting
2024-05-01 16:30 Q1 2024 Earnings Call
2024-05-01 16:05 Q1 2024 Earnings Release
2024-03-12 15:05 Barclays Global Healthcare Conference
2024-03-11 10:00 Leerink Partners Global Biopharma Conference
2024-02-28 16:30 Q4 2023 Earnings Call
2024-02-28 16:05 Q4 2023 Earnings Release
2024-01-29 08:30 SRP-5051-201 Phase 2 Part B Study Results Call
2024-01-29 08:30 SRP-5051-201 Phase 2 Part B Study Results Call
2024-01-08 12:00 JPMorgan Healthcare Conference
2023-11-09 09:00 UBS BioPharma Conference
2023-11-01 16:30 Q3 2023 Earnings Call
2023-11-01 16:05 Q3 2023 Earnings Release
2023-10-30 16:30 Business Update Call
2023-09-11 08:40 Morgan Stanley Global Healthcare Conference
2023-08-02 16:30 Q2 2023 Earnings Call
2023-08-02 16:05 Q2 2023 Earnings Release
2023-07-10 11:00 Cowen RNA Therapeutics Summit
2023-06-22 16:30 ELEVIDYS FDA Approval Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		381
379
0.54%		540
537
0.61%		702
689
1.8%		933
925
0.86%		1 243
1 233
0.87%
2 016

EBITDA
Million USD		Released
Forecast
Spread 		-681
-596
-14.33%		-537
-535
-0.4%		-422
-479
11.97%		-494
-518
4.49%		-223
-278
19.63%
269

EBIT
Million USD		Released
Forecast
Spread 		-706
-611
-15.49%		-564
-518
-8.89%		-460
-460
-0.03%		-536
-517
-3.66%		-268
-303
11.68%
281

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-714
-618
-15.52%		-553
-522
-6%		-419
-433
3.28%		-690
-708
2.57%		-520
-559
6.94%
301

Net income
Million USD		Released
Forecast
Spread 		-715
-617
-15.85%		-554
-519
-6.72%		-419
-438
4.35%		-703
-677
-3.95%		-536
-579
7.41%
318

EPS
USD		Released
Forecast
Spread 		-9,71
-8,44
-15.05%		-7,11
-6,66
-6.71%		-5,15
-5,20
0.98%		-8,03
-7,54
-6.49%		-5,80
-6,39
9.19%
3,60

Announcement Date26/02/2001/03/2101/03/2228/02/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		211
208
1.24%		233
221
5.56%		230
235
-1.83%		258
251
3.16%		254
241
4.98%		261
262
-0.36%		332
287
15.71%		397
386
2.75%		413
375
10.13%
392


523


675


773


842

EBIT
Million USD		Released
Forecast
Spread 		-86,9
-109
20.02%		-211
-92,7
-127.71%		-131
-112
-17.53%		-107
-105
-1.92%		-138
-116
-19.22%		-134
-169
21.04%		-20,8
-120
82.64%		24,6
-7,43
431.59%		34,9
-18,3
290.45%
-6,53


71,0


191


257


279

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-104
-115
9.58%		-228
-99,6
-128.92%		-256
-132
-93.89%		-101
-115
11.92%		-513
-129
-298.57%		-14,6
-156
90.67%		-33,2
-105
68.47%		40,4
4,23
854.54%		41,4
-12,3
436.79%
15,5


97,6


210


254


281

Net income
Million USD		Released
Forecast
Spread 		-105
-118
10.76%		-231
-101
-129.34%		-258
-122
-111.7%		-109
-103
-6.06%		-517
-116
-343.89%		-23,9
-164
85.42%		-40,9
-115
64.4%		45,7
-5,49
931.45%		36,1
-3,63
1094.49%
14,9


108


237


227


251

EPS
USD		Released
Forecast
Spread 		-1,20
-1,35
11.25%		-2,65
-1,15
-130.76%		-2,94
-1,41
-109.25%		-1,24
-1,18
-5.21%		-5,86
-1,29
-353.43%		-0,27
-1,80
85.01%		-0,46
-1,26
63.38%		0,47
-0,05
1083.47%		0,37
0,02
2366.67%
0,09


1,11


2,27


2,96


3,30

Announcement Date04/05/2202/08/2202/11/2228/02/2302/05/2302/08/2301/11/2328/02/2401/05/24-----

Upcoming sector events for Sarepta Therapeutics, Inc.

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Sarepta Therapeutics, Inc.

2024-06-05 03:51 PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
2024-05-17 07:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
2024-05-15 08:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-14 16:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 16:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SRPT Stock
  4. S1RP34 Stock
  5. Calendar Sarepta Therapeutics, Inc.